These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26756217)

  • 1. Generation and characterization of a tetraspanin CD151/integrin α6β1-binding domain competitively binding monoclonal antibody for inhibition of tumor progression in HCC.
    Ke AW; Zhang PF; Shen YH; Gao PT; Dong ZR; Zhang C; Cai JB; Huang XY; Wu C; Zhang L; Kang Q; Liu LX; Xie N; Shen ZZ; Hu MY; Cao Y; Qiu SJ; Sun HC; Zhou J; Fan J; Shi GM
    Oncotarget; 2016 Feb; 7(5):6314-22. PubMed ID: 26756217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling of the tetraspanin CD151 web and conspiracy of CD151/integrin β1 complex in the progression of hepatocellular carcinoma.
    Devbhandari RP; Shi GM; Ke AW; Wu FZ; Huang XY; Wang XY; Shi YH; Ding ZB; Xu Y; Dai Z; Fan J; Zhou J
    PLoS One; 2011; 6(9):e24901. PubMed ID: 21961047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective tetraspan-integrin complexes (CD81/alpha4beta1, CD151/alpha3beta1, CD151/alpha6beta1) under conditions disrupting tetraspan interactions.
    Serru V; Le Naour F; Billard M; Azorsa DO; Lanza F; Boucheix C; Rubinstein E
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):103-11. PubMed ID: 10229664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma.
    Shi GM; Ke AW; Zhou J; Wang XY; Xu Y; Ding ZB; Devbhandari RP; Huang XY; Qiu SJ; Shi YH; Dai Z; Yang XR; Yang GH; Fan J
    Hepatology; 2010 Jul; 52(1):183-96. PubMed ID: 20578262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. I
    Wu L; Sun B; Lin X; Liu C; Qian H; Chen L; Yang Y; Shen F; Su C
    Genes Cells; 2018 Jan; 23(1):35-45. PubMed ID: 29210217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the tetraspanin CD151 with the laminin-binding integrins alpha3beta1, alpha6beta1, alpha6beta4 and alpha7beta1 in cells in culture and in vivo.
    Sterk LM; Geuijen CA; van den Berg JG; Claessen N; Weening JJ; Sonnenberg A
    J Cell Sci; 2002 Mar; 115(Pt 6):1161-73. PubMed ID: 11884516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function of the tetraspanin CD151-alpha6beta1 integrin complex during cellular morphogenesis.
    Zhang XA; Kazarov AR; Yang X; Bontrager AL; Stipp CS; Hemler ME
    Mol Biol Cell; 2002 Jan; 13(1):1-11. PubMed ID: 11809818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetraspanin CD151 regulates alpha6beta1 integrin adhesion strengthening.
    Lammerding J; Kazarov AR; Huang H; Lee RT; Hemler ME
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7616-21. PubMed ID: 12805567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin α6β1 Expressed in ESCs Instructs the Differentiation to Endothelial Cells.
    Toya SP; Wary KK; Mittal M; Li F; Toth PT; Park C; Rehman J; Malik AB
    Stem Cells; 2015 Jun; 33(6):1719-29. PubMed ID: 25693840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tetraspanin CD151 and integrin α6β1 mediate platelet-enhanced endothelial colony forming cell angiogenesis.
    Huang Z; Miao X; Patarroyo M; Nilsson GP; Pernow J; Li N
    J Thromb Haemost; 2016 Mar; 14(3):606-18. PubMed ID: 26749288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD151 amplifies signaling by integrin α6β1 to PI3K and induces the epithelial-mesenchymal transition in HCC cells.
    Ke AW; Shi GM; Zhou J; Huang XY; Shi YH; Ding ZB; Wang XY; Devbhandari RP; Fan J
    Gastroenterology; 2011 May; 140(5):1629-41.e15. PubMed ID: 21320503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma.
    Ke AW; Shi GM; Zhou J; Wu FZ; Ding ZB; Hu MY; Xu Y; Song ZJ; Wang ZJ; Wu JC; Bai DS; Li JC; Liu KD; Fan J
    Hepatology; 2009 Feb; 49(2):491-503. PubMed ID: 19065669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis.
    Testa JE; Brooks PC; Lin JM; Quigley JP
    Cancer Res; 1999 Aug; 59(15):3812-20. PubMed ID: 10447000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD151 promotes cancer cell metastasis via integrins α3β1 and α6β1 in vitro.
    Fei Y; Wang J; Liu W; Zuo H; Qin J; Wang D; Zeng H; Liu Z
    Mol Med Rep; 2012 Dec; 6(6):1226-30. PubMed ID: 23007325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of human hepatoma growth in vivo by a monoclonal antibody against a Mr 45,000 protein.
    Lin Y; Feng J; Yang D; Shen Y; Yan X
    Cancer Invest; 2006 Dec; 24(8):734-9. PubMed ID: 17162555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
    Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of truncated tissue factor antineuropilin-1 monoclonal antibody conjugate and identification of its selective thrombosis in tumor blood vessels.
    Xu P; Zou M; Wang S; Wang L; Wang L; Luo F; Wu T; Yan J
    Anticancer Drugs; 2019 Jun; 30(5):441-450. PubMed ID: 30807552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel monoclonal antibody to fibroblast growth factor 2 effectively inhibits growth of hepatocellular carcinoma xenografts.
    Wang L; Park H; Chhim S; Ding Y; Jiang W; Queen C; Kim KJ
    Mol Cancer Ther; 2012 Apr; 11(4):864-72. PubMed ID: 22351746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma.
    Xiao Z; Chung H; Banan B; Manning PT; Ott KC; Lin S; Capoccia BJ; Subramanian V; Hiebsch RR; Upadhya GA; Mohanakumar T; Frazier WA; Lin Y; Chapman WC
    Cancer Lett; 2015 May; 360(2):302-9. PubMed ID: 25721088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortalin stabilizes CD151-depedent tetraspanin-enriched microdomains and implicates in the progression of hepatocellular carcinoma.
    Liu LX; Lu JC; Zeng HY; Cai JB; Zhang PF; Guo XJ; Huang XY; Dong RZ; Zhang C; Kang Q; Zou H; Zhang XY; Zhang L; Zhang XW; Ke AW; Shi GM
    J Cancer; 2019; 10(25):6199-6206. PubMed ID: 31772652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.